Chest 2021 Annual Meeting

Hospitalization Rates Stable, But Diabetes Less Common, Among PAH Patients

The hospitalization rate and in-hospital mortality among patients with pulmonary arterial hypertension (PAH) seem to be stable in the US, according to a new study published in the journal Chest and presented at the Chest 2021 Annual Meeting. However, the proportion of diabetes among these patients seems to have decreased. Studies conducted before 2013 suggested…

Study Suggests PAH Patients Need Special Attention During Intubation

Mechanically ventilated pulmonary arterial hypertension (PAH) patients have a worse outcome than similar patients without PAH, according to a study published in Chest and presented at the Chest 2021 Annual Meeting. The researchers also reported that the first 24 hours after intubation is a particularly vulnerable period that may be crucial for the long-term outcomes…

Patients With IPF and GERD Showed Higher Risk for Poor Outcomes

There is an association between idiopathic pulmonary fibrosis (IPF) and gastroesophageal reflux disease (GERD), according to results published in Chest. The study is being presented virtually at the Chest 2021 Annual Meeting on Oct. 17-20, 2021. The association between IPF and GERD was already known possibly due to chronic micro-aspiration leading to lung parenchyma remodeling.…

woman coughing

Importance of AATD Patients Recognizing Exacerbations in Pulmonary Symptoms

Changes in usual lung symptoms are not universally recognized as exacerbations, according to a new study published in the journal Chest and being presented at the Chest 2021 Annual Meeting. The correlation between symptom-based exacerbation and the definition of an exacerbation based on health care utilization is not high.  Identifying pulmonary exacerbations in patients with…

IPF exercise

Dedicated ILD Clinic Care Improves the Monitoring of Patients With IPF

A dedicated interstitial lung disease (ILD) clinic improves the care provided to patients with idiopathic pulmonary fibrosis (IPF), according to a recent study conducted by Gross et al. Improvements were observed even in clinics located in small healthcare systems, regardless of their association with a tertiary care center. The results of the study will be…

Rare Pancreatic Tumors Could Be a Comorbidity in Patients With PAH

Intraductal papillary mucinous neoplasms (IPMNs) could increasingly be seen as a comorbidity in patients with pulmonary arterial hypertension (PAH), especially as their life expectancy increases. This is according to a new case study published in the Chest journal and being presented at the Chest 2021 Annual Meeting. More research is needed to see whether the…

Case Report: Pulmonary Arterial Hypertension Due to Vitamin C Deficiency

Severe vitamin C deficiency is a rare cause of pulmonary arterial hypertension (PAH) that is easily treatable, according to a case study by Shrey Shah and colleagues published in Chest and being presented at the Chest 2021 Annual Meeting. It should, therefore, be considered in the appropriate clinical setting. The researchers presented the case of…

Next post in PAH News Briefs